Now accepting Telehealth appointments. Schedule a virtual visit.

More About Dysthymic Disorders

Persistent depressive disorder, or also known as dysthymia, is a chronic form of depression. Similar to to effects of depression, an individual can lose interest in normal daily activities, feel hopeless, lack productivity, and have low self esteem. These feelings can last for years and can eventually influence and individual's lifestyle including one's relationships, school, and work. Although dysthymic disorder is not as severe as major depression, the depressed mood can range from being mild, moderate, or severe. It may be difficult to find interest in activities even during happy occasions and individuals can be described as incapable of having fun or having a gloomy personality. Due to its chronic symptoms, coping with these symptoms can be difficult however, there are various ways in which an individual can treat this condition. 

The symptoms of dysthymia can come and go and can exist in varying intensities over time. These symptoms, if left untreated can lead to significant impairment, include:

While the causes of this disorder can vary from a wide range such as genetically linked traits, a significant life event, unstable brain chemistry, and even biological differences, there are steps to take toward prevention. Some strategies to help lower the risk factors of these symptoms include:

If you need further help or would like more information, visit this link or give us a call. 

You Might Also Enjoy...

988 - A Mental Health Lifeline

988 is a mental health crisis line. A shortened version of the 1-800-273-TALK (8255), this line is specifically used for any mental health related emergency.

TMS and Its Wide Application

FDA's approval of TMS for Major Depressive Disorder (MDD) in 2008 has sparked researchers to take a dive and explore further implications of TMS for other drug-resistant psychiatric disorders.

TMS for Parkinson's Disease

Read about how transcranial magnetic stimulation (TMS) can be used to help target the motor symptoms of Parkinson's disease.

SAINT Protocol Now Cleared by the FDA

Read about how the Stanford Accelerated Intelligent Neuromodulation Therapy (SAINT) for the treatment of major depressive disorder is now cleared by the US Food & Drug Administration (FDA).